Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pignata

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trialD Lorusso, G Scambia, S Pignata, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2017
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network settingI Ray-Coquard, AnnaLisa Trama, M J Seckl, et al.
ESMO Open|December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]L Arenare, R Di Liello, P De Placido, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyF Perrone, C Jommi, M Di Maio, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 14, 2026
Particle Beam Re-irradiation in Oligo Recurrent Gynecological MalignanciesA Barcellini, A Vai, G Fontana, et al.
Current Cancer Drug Targets|June 29, 2010
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancerC D'Alterio, C Consales, M Polimeno, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)C D'Alterio, G Rea, M Napolitano, et al.
Gynecologic Oncology|November 4, 2019
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trialD Lorusso, G Ferrandina, N Colombo, et al.
Gynecologic Oncology|June 14, 2019
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Cormio, G Ferrandina, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trialD Lorusso, G Scambia, S Pignata, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2017
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network settingI Ray-Coquard, AnnaLisa Trama, M J Seckl, et al.
ESMO Open|December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]L Arenare, R Di Liello, P De Placido, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyF Perrone, C Jommi, M Di Maio, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 14, 2026
Particle Beam Re-irradiation in Oligo Recurrent Gynecological MalignanciesA Barcellini, A Vai, G Fontana, et al.
Current Cancer Drug Targets|June 29, 2010
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancerC D'Alterio, C Consales, M Polimeno, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)C D'Alterio, G Rea, M Napolitano, et al.
Gynecologic Oncology|November 4, 2019
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trialD Lorusso, G Ferrandina, N Colombo, et al.
Gynecologic Oncology|June 14, 2019
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Cormio, G Ferrandina, et al.
Pageof 12